Savoy Pharmaceuticals™, a privately held company, is developing innovative products with the potential to treat many types of cancer and
terminal viral diseases including: liver cancer, pancreatic cancer, breast cancer, colon cancer, Hepatitis C, HIV, and Herpes. In pre-clinical trials Savoy's
products have been shown to have little to no effect on normal cells. This makes it the first of its kind to treat terminal diseases while
leaving normal, healthy tissue unharmed.